Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Post-COVID conditions increase health care needs for six months after infection.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

COVID-19 can cause skin changes, possibly from the virus, drugs, or lifestyle changes.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

COVID-19 temporarily affects male reproductive health, but sperm and testosterone levels generally return to normal after three months.

Dermatologists should watch for skin symptoms in COVID-19 patients, prioritize urgent cases, and use telemedicine.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Testosterone may influence COVID-19 severity and outcomes.

Women with high androgen levels may have more severe COVID-19 symptoms.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Higher caspase-1 levels found in balding scalps; reducing it may help treat hair loss.

COVID-19 can cause a type of hair loss that usually starts 74 days after infection, affecting mostly women, but most patients eventually recover.

COVID-19 infection can significantly cause temporary hair loss.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

COVID-19 affected Black communities more in Oakland County, MI, but didn't increase death rates.

COVID-19 increased alopecia areata relapses due to inflammation and stress.

COVID-19 may trigger systemic lupus erythematosus, requiring careful diagnosis and treatment.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

COVID-19 may cause temporary hair loss in some people.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

COVID-19 may harm male fertility and damage the reproductive system.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

COVID-19 can directly trigger certain skin conditions like pustular dermatoses due to an inflammatory response.

COVID-19 patients may experience temporary hair loss, mainly in women, which is likely reversible.